Skip to main content
. Author manuscript; available in PMC: 2009 Dec 15.
Published in final edited form as: Clin Cancer Res. 2008 Dec 15;14(24):8213–8220. doi: 10.1158/1078-0432.CCR-08-0095

Figure 1.

Figure 1

Validation of the 35-gene prognostic signature in two patient cohorts. A. Patients in Garber’s cohort (n = 24) were classified into high- and low-risk groups based on the correlation with the good prognostic centroid in Beer’s cohort. Each tumor sample was classified as low-risk if the correlation coefficient is greater than 0.32; otherwise, it is classified as high-risk. B. The same cutoff was applied to Bild’s cohort (n = 111) in patient stratification. Kaplan-Meier analysis was used to assess the survival rates of different prognostic groups.